AI Verdict
PCOR has stronger fundamentals based on our AI analysis.
PCRX vs PCOR Fundamental Comparison
| Metric | PCRX | PCOR |
|---|---|---|
| Revenue | $726.4M | $1.3B |
| Net Income | $7.0M | $-100.8M |
| Net Margin | 1.0% | -7.6% |
| ROE | 1.0% | -8.0% |
| ROA | 0.6% | -4.5% |
| Current Ratio | 4.54x | 1.32x |
| Debt/Equity | 0.54x | 0.00x |
| EPS | $0.16 | $-0.67 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCRX vs PCOR: Frequently Asked Questions
Is PCRX or PCOR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PCOR has stronger fundamentals. PCRX is rated HOLD (65% confidence) while PCOR is rated BUY (68% confidence). This is not investment advice.
How does PCRX compare to PCOR fundamentally?
Pacira BioSciences, Inc. has ROE of 1.0% vs PROCORE TECHNOLOGIES, INC.'s -8.0%. Net margins are 1.0% vs -7.6% respectively.
Which stock pays higher dividends, PCRX or PCOR?
PCRX has a dividend yield of N/A or no dividend while PCOR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCRX or PCOR for long term?
For long-term investing, consider that PCRX has HOLD rating with 65% confidence, while PCOR has BUY rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCRX vs PCOR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCRX vs PCOR, the AI consensus favors PCOR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.